Literature DB >> 21283126

Combination therapy: hypoxia modification with radiotherapy for bladder cancer.

Mary Gospodarowicz1.   

Abstract

Entities:  

Year:  2011        PMID： 21283126     DOI： 10.1038/nrclinonc.2011.5

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  What is the role of radiotherapy in bladder-preserving cancer therapy?

Authors:  Claus Rödel; Rolf Sauer
Journal:  Nat Clin Pract Oncol       Date:  2005-01

Review 2.  Radiochemotherapy for bladder cancer.

Authors:  O J Ott; C Rödel; C Weiss; M Wittlinger; F St Krause; J Dunst; R Fietkau; R Sauer
Journal:  Clin Oncol (R Coll Radiol)       Date:  2009-06-28       Impact factor: 4.126

3.  Irradiation with misonidazole and hyperbaric oxygen: final report on a randomized trial in advanced head and neck cancer.

Authors:  R Sealy; S Cridland; L Barry; R Norris
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-08       Impact factor: 7.038

Review 4.  Adaptive management of bladder cancer radiotherapy.

Authors:  Floris Pos; Peter Remeijer
Journal:  Semin Radiat Oncol       Date:  2010-04       Impact factor: 5.934

5.  Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.

Authors:  C M Coppin; M K Gospodarowicz; K James; I F Tannock; B Zee; J Carson; J Pater; L D Sullivan
Journal:  J Clin Oncol       Date:  1996-11       Impact factor: 44.544

6.  Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma.

Authors:  Peter J Hoskin; Ana M Rojas; Søren M Bentzen; Michele I Saunders
Journal:  J Clin Oncol       Date:  2010-10-18       Impact factor: 44.544

7.  Behavior of lipiodol markers during image guided radiotherapy of bladder cancer.

Authors:  Xiangfei Chai; Marcel van Herk; Jeroen B van de Kamer; Peter Remeijer; Axel Bex; Anja Betgen; Theo M De Reijke; Maarten C C M Hulshof; Floris J Pos; Arjan Bel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-04       Impact factor: 7.038

Review 8.  Clinical studies of hypoxia modification in radiotherapy.

Authors:  Johannes H A M Kaanders; Johan Bussink; Albert J van der Kogel
Journal:  Semin Radiat Oncol       Date:  2004-07       Impact factor: 5.934

Review 9.  Radiotherapy for bladder cancer.

Authors:  Michael Milosevic; Mary Gospodarowicz; Anthony Zietman; Farhat Abbas; Karin Haustermans; Luc Moonen; Claus Rödel; Mark Schoenberg; William Shipley
Journal:  Urology       Date:  2007-01       Impact factor: 2.649

10.  Lipiodol injection for target volume delineation and image guidance during radiotherapy for bladder cancer.

Authors:  Floris Pos; Axel Bex; Hermina Maria Dees-Ribbers; Anja Betgen; Marcel van Herk; Peter Remeijer
Journal:  Radiother Oncol       Date:  2009-10-01       Impact factor: 6.280
  10 in total
  1 in total

1.  Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion.

Authors:  Mei Xue; Xu Li; Zhengkun Li; Wei Chen
Journal:  Tumour Biol       Date:  2014-04-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.